Risk stratification groups based on the circulating PCs and risk factors used in ISS
. | No. patients at risk (%) . | Median survival, mo . |
|---|---|---|
| Risk factor | ||
| B2M, more than 3.5 mg/L | 190 | 41 |
| Albumin level, less than 3.5 g/dL | 127 | 28 |
| Circulating PCs, more than 10 | 115 | 37 |
| Risk stratification group | ||
| Low-risk (none of the risk factors present) | 56 (19) | 79+ |
| Low-intermediate risk (1 of the risk factors present) | 98 (32) | 48 |
| High-intermediate risk (2 of the risk factors present) | 91 (30) | 32 |
| High risk (3 risk factors present) | 57 (19) | 13 |
. | No. patients at risk (%) . | Median survival, mo . |
|---|---|---|
| Risk factor | ||
| B2M, more than 3.5 mg/L | 190 | 41 |
| Albumin level, less than 3.5 g/dL | 127 | 28 |
| Circulating PCs, more than 10 | 115 | 37 |
| Risk stratification group | ||
| Low-risk (none of the risk factors present) | 56 (19) | 79+ |
| Low-intermediate risk (1 of the risk factors present) | 98 (32) | 48 |
| High-intermediate risk (2 of the risk factors present) | 91 (30) | 32 |
| High risk (3 risk factors present) | 57 (19) | 13 |